Try GOLD - Free
Anthem puts spotlight on a red hot mkt
Mint Mumbai
|July 16, 2025
In the grey market, Anthem shares were quoting at ₹679—about 19% above the issue price
The initial public offering of Bengaluru-based Anthem Biosciences, a contract research and innovation provider, has thrown the spotlight on India's contract development and manufacturing organization (CDMO) space.
On Day 1, the IPO was subscribed 0.7x overall. Among non-institutional investors, bids above ₹10 lakh were subscribed 1.37x, and those between ₹2 lakh and ₹10 lakh saw nearly 2x subscription, NSE data showed.
In the grey market, Anthem shares were quoting at ₹679—about 19% above the issue price, according to IPO data platform Investor Gain.
The excitement isn't limited to Anthem. Shares of CDMO players have been surging. From July 2023 to mid-July 2024, Divi's Laboratories gained 49%, Aarti Pharmalabs rose 53%, Piramal Pharma climbed 38%, and Cohance Lifesciences advanced 22%.
In contrast, generic pharma majors underwhelmed. Sun Pharma is up just 7%, Cipla and Dr. Reddy's have slipped 2% and 7% respectively, while Torrent Pharma posted a modest 15.5% rise and Aurobindo Pharma fell 14%.
This story is from the July 16, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Bank-funded acquisitions won't displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Air India lobbies to use airspace over China's Xinjiang
India-China flights resumed after a five-year hiatus.
1 mins
November 20, 2025
Mint Mumbai
Nitish Kumar to take oath as Bihar CM
JD(U) supremo Nitish Kumar to be sworn-in as Bihar chief minister for a record 10th time.
1 min
November 20, 2025
Mint Mumbai
A fresh perspective on abstraction in art
A new exhibition in Mumbai showcases different approaches to abstraction by artists like Zarina, Seher Shah and Mehlli Gobhai
3 mins
November 20, 2025
Mint Mumbai
Govt eyes post-cut GST revenue surge
FinMin expects Nov GST receipts growth to rebound to 10%
2 mins
November 20, 2025
Mint Mumbai
PayMate pulls plug on West Asia operations
The Visa-backed B2B payments firm is scrambling to raise more funds
2 mins
November 20, 2025
Mint Mumbai
Exide's dual bet: Can lithium-ion offset a weakening core?
Exide Industries Ltd is struggling to fuel its core lead-acid business while simultaneously turning its capex-heavy lithium-ion venture into a viable second growth engine.
1 mins
November 20, 2025
Mint Mumbai
Bank-funded acquisitions won’t displace private credit
The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.
3 mins
November 20, 2025
Mint Mumbai
Afghanistan trade minister seeks India investments, goods
Afghanistan's Taliban trade minister arrived in India on Wednesday on a maiden visit to draw greater investments and goods as both countries consider ways to enhance their relations in the backdrop of souring relations with neighboring Pakistan.
1 min
November 20, 2025
Mint Mumbai
Fractal Analytics bets heavily on R&D in AI race before IPO
Enterprise artificial intelligence firm Fractal Analytics plans to maintain high research and development (R&D) spending ahead of its market debut for which a date has not yet been set, a top executive has said.
2 mins
November 20, 2025
Listen
Translate
Change font size

